Trial Condition(s):

Common Cold

Acetylsalicylic acid combined with pseudoephedrine in common cold

Bayer Identifier:

13700

ClinicalTrials.gov Identifier:

NCT00963443

EudraCT Number:

2009-011355-46

Study Completed

Trial Purpose

The purpose of the study is to determine the effectiveness of an acetylsalicylic acid (aspirin) pseudoephedrine combination for the treatment of pain and congestion symptoms compared to the effectiveness of the individual components of the medicine and the placebo (dummy treatment that looks like the real thing).The combination product of acetylsalicylic acid / pseudoephedrine is already marketed in several European countries as Aspirin® Complex.

Inclusion Criteria
- Patient in general good health with suspected viral upper respiratory tract infection (common cold)
Exclusion Criteria
- < 18 years old

Trial Summary

Enrollment Goal
833
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
Yes
Products
Aspirin (Acetylsalicylic Acid, BAYE4465)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Cardiff University

Cardiff, United Kingdom, CF1 3US

Status
Completed
 

Trial Design